Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Gross Profit (2020 - 2025)

Historic Gross Profit for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $39.7 million.

  • Treace Medical Concepts' Gross Profit rose 989.15% to $39.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $174.8 million, marking a year-over-year increase of 690.88%. This contributed to the annual value of $168.3 million for FY2024, which is 1074.59% up from last year.
  • As of Q3 2025, Treace Medical Concepts' Gross Profit stood at $39.7 million, which was up 989.15% from $37.8 million recorded in Q2 2025.
  • Over the past 5 years, Treace Medical Concepts' Gross Profit peaked at $55.5 million during Q4 2024, and registered a low of $15.4 million during Q1 2021.
  • Over the past 5 years, Treace Medical Concepts' median Gross Profit value was $34.3 million (recorded in 2023), while the average stood at $33.3 million.
  • Per our database at Business Quant, Treace Medical Concepts' Gross Profit skyrocketed by 19554.3% in 2021 and then soared by 222.54% in 2025.
  • Quarter analysis of 5 years shows Treace Medical Concepts' Gross Profit stood at $28.1 million in 2021, then surged by 45.17% to $40.7 million in 2022, then grew by 24.53% to $50.7 million in 2023, then grew by 9.33% to $55.5 million in 2024, then dropped by 28.43% to $39.7 million in 2025.
  • Its last three reported values are $39.7 million in Q3 2025, $37.8 million for Q2 2025, and $41.9 million during Q1 2025.